NanoTess Secures Deal to Put Its Product in 14,000 Canadian Pharmacies

NanoTess has secured a deal with the Canadian division of Embecta to put its flagship skin health and wound healing solution NanoSALV in 14,000 pharmacies across the country, reports BetaKit. 

NanoSALV is a Health Canada approved gel-like substance that optimizes the body’s own healing mechanisms so chronic wounds like diabetic foot ulcers heal faster. Embecta is a global medical device company focused on improving the lives of those living with diabetes.  

Read more about this impactful partnership in the Betakit article here. 

Thanks Betakit for the coverage!

‍